The share allotment is routine and immaterial. Monitor next quarterly filing for any acceleration in option exercises that could signal insider sentiment.
RDY drugs
RDY drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 4 $14.77entry
- T+1 · 12d ago −1.62%α +2.78% · $14.53
- T+5 · 6d ago +0.47%α +1.39% · $14.84
- T+8 · todayOpen
- T+20 · in 16d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Dr. Reddy's Laboratories filed a Form 6-K reporting the allotment of 591,270 equity shares to employees upon exercise of stock options under the company's ADR Stock Option Scheme, 2007. This is a routine equity issuance for employee compensation, with no material financial impact or change in business operations.
Key Facts
- Allotted 591,270 equity shares of Re.1 each on November 4, 2026
- Shares issued under Dr. Reddy's Employees ADR Stock Option Scheme, 2007
- Exercise prices ranged from Re.1 to Rs.1,060.20 per share
- Total issued shares after allotment: 83,527,2555 (including 1,000 forfeited shares)
- New shares rank pari passu with existing shares
Financial Impact
591,270 shares allotted, representing approximately 0.07% of total issued shares (83.5 million). No material financial impact.
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000759 |
| Document: 0001575872-26-000759-index.html | 0001575872-26-000759 |
| Document: 0001575872-26-000759.txt | 0001575872-26-000759 |
| Earnings Context (Synthetic; results releases only) | 0001575872-26-000759 |
Track record
73 reports on RDY
7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.
Filters
- Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
- Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
- Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
- Nov 4, 202612d ago 6-K Neutral 2/10 Viewing Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
- Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
- Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers